Exodus Point Capital Management, LP Sorrento Therapeutics, Inc. Transaction History

Exodus Point Capital Management, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$1.51 - $2.88 $66,791 - $127,391	44,233 New	44,233 $69,000
Q2 2022 Aug 19, 2022	SELL	$1.24 - $2.33 $139,183 - $261,530	-112,245 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$2.0 - $4.9 $224,490 - $550,000	112,245 New	112,245 $262,000
Q3 2021 Nov 15, 2021	SELL	$7.41 - $10.99 $565,583 - $838,833	-76,327 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$6.35 - $10.0 $484,676 - $763,270	76,327 New	76,327 $740,000
Q1 2021 May 17, 2021	SELL	$7.03 - $16.51 $351,500 - $825,500	-50,000 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$5.76 - $11.95 $56,943 - $118,137	-9,886 Reduced 16.51%	50,000 $341,000
Q3 2020 Nov 16, 2020	BUY	$6.17 - $18.82 $369,496 - $1.13 Million	59,886 New	59,886 $668,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.